Page 4 - இந்தோ எங்களுக்கு தடுப்பூசி நடவடிக்கை ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இந்தோ எங்களுக்கு தடுப்பூசி நடவடிக்கை ப்ரோக்ர்யாம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இந்தோ எங்களுக்கு தடுப்பூசி நடவடிக்கை ப்ரோக்ர்யாம் Today - Breaking & Trending Today

15 Billion Vaccine Doses Needed to Fight Global COVID Pandemic: Can India, Pharmacy to the World, Meet Demand?


More than 15 billion doses of various COVID-19 vaccines are required to fight the global COVID pandemic, but can India, in partnership with the U.S., rise to meet the demand?
India produces 20 percent of all pharmaceuticals consumed worldwide, making the country the largest manufacturer and supplier of drugs. More than 40 percent of pharmaceuticals consumed in the U.S. are made in India, earning the country the moniker of “pharmacy to the world.”
At an April 7 discussion — “Strengthening U.S.-India Pharma and Vaccine Diplomacy — jointly organized by the Confederation of Indian Industry and the U.S. Consulate in Mumbai, panelists noted that U.S. and India politics will stall the rate at which vaccines are distributed around the globe, and urged both countries to broaden their scope of vaccine diplomacy, in the mode of China, which has been aggressive in getting its vaccine into the developing world. ....

Andhra Pradesh , United States , United Kingdom , South Africa , South African , Jonathan Kimball , Adar Poonawalla , Us India Pharma , Suresh Jadhav , Suchitra Ella , Indo Us Vaccine Action Program , Serum Institute , Melinda Gates Foundation , Confederation Of Indian Industry , Serum Institute Of India , Association For Accessible Medicines , India Pharma , Vaccine Diplomacy , Indian Industry , Action Program , Accessible Medicines , Bharat Biotech , ஆந்திரா பிரதேஷ் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , ஜொனாதன் கிஂப்யால் ,

India reinforces its reputation as the 'pharmacy of the world'


RIYADH: On Jan. 16, Indian Prime Minister Narendra Modi launched the world’s largest coronavirus vaccination program in India. Its target is to inoculate 300 million people by August 2021. More than a million received their first dose within a week of the launch.
Over the past several months, more than 30 Indian groups from academia and industry have been involved in the development, collaboration and trials of the COVID-19 vaccines in India. Six vaccine candidates, including three indigenously developed ones, have reached the clinical stages of development. Two vaccines Covishield, licensed from AstraZeneca and Oxford University and produced by the Serum Institute of India, and Covaxin, indigenously developed by Bharat Biotech in partnership with the Indian Council of Medical Research (ICMR) have been approved for emergency use in the country. ....

Saudi Arabia , Ar Riya , Narendra Modi , Atmanirbhar Bharat , Us National Institute Of Health , Indo Us Vaccine Action Program , Indian Council Of Medical Research , Department Of Biotechnology , Serum Institute , Serum Institute Of India , Oxford University , Indian Prime Minister Narendra Modi , Bharat Biotech , Indian Council , Medical Research , Pune Based Serum Institute , Action Program , Global Vaccine Summit , Prime Minister Modi , சவுதி அரேபியா , ஆர் ரியா , நரேந்திர மோடி , எங்களுக்கு தேசிய நிறுவனம் ஆஃப் ஆரோக்கியம் , இந்தோ எங்களுக்கு தடுப்பூசி நடவடிக்கை ப்ரோக்ர்யாம் , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , துறை ஆஃப் உயிரி தொழில்நுட்பவியல் ,